Compare VOR & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOR | MNSB |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.1M | 140.1M |
| IPO Year | 2021 | N/A |
| Metric | VOR | MNSB |
|---|---|---|
| Price | $13.45 | $20.97 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $66.63 | N/A |
| AVG Volume (30 Days) | ★ 3.5M | 43.9K |
| Earning Date | 11-13-2025 | 01-26-2026 |
| Dividend Yield | N/A | ★ 1.87% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $69,367,000.00 |
| Revenue This Year | N/A | $23.19 |
| Revenue Next Year | N/A | $2.92 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.71 |
| 52 Week Low | $2.62 | $15.00 |
| 52 Week High | $65.80 | $22.98 |
| Indicator | VOR | MNSB |
|---|---|---|
| Relative Strength Index (RSI) | 53.01 | 59.51 |
| Support Level | $7.91 | $19.68 |
| Resistance Level | $16.80 | $22.20 |
| Average True Range (ATR) | 1.78 | 0.55 |
| MACD | 0.90 | 0.08 |
| Stochastic Oscillator | 63.59 | 51.19 |
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.